USP9X, affected in 4 out of 20 IBC cases by a germline variant, is a deubiquitinating enzyme that controls SMAD4 mono-ubiquitination and therefore affects TGFβ signaling [49]. This evidence concerns the gene TGFB1 and inflammatory breast carcinoma.